These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24203066)

  • 1. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
    Gannon AW; Monk HM; Levine MA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):7-11. PubMed ID: 24203066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q mutation: clinical benefit from cinacalcet.
    Reh CM; Hendy GN; Cole DE; Jeandron DD
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E707-12. PubMed ID: 21289269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
    Atay Z; Bereket A; Haliloglu B; Abali S; Ozdogan T; Altuncu E; Canaff L; Vilaça T; Wong BY; Cole DE; Hendy GN; Turan S
    Bone; 2014 Jul; 64():102-7. PubMed ID: 24735972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet therapy in an infant with an R185Q calcium-sensing receptor mutation causing hyperparathyroidism: a case report and review of the literature.
    Forman TE; Niemi AK; Prahalad P; Shi RZ; Nally LM
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):305-310. PubMed ID: 30730839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
    Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
    Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.
    Sun X; Huang L; Wu J; Tao Y; Yang F
    Medicine (Baltimore); 2018 Nov; 97(45):e13128. PubMed ID: 30407334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene.
    Özgüç Çömlek F; Demir S; Gürkan H; İnan M; Sezer A; Dilek E; Kökenli F
    Pediatr Endocrinol Diabetes Metab; 2022; 28(2):168-174. PubMed ID: 35399047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia.
    Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM
    Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet therapy in a child with novel homozygous CASR p.Glu353Lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature.
    Koca SB
    Turk J Pediatr; 2023; 65(5):853-861. PubMed ID: 37853976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
    Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
    Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
    Marx SJ; Sinaii N
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: A case report and review of the literature.
    Aubert-Mucca M; Dubucs C; Groussolles M; Vial J; Le Guillou E; Porquet-Bordes V; Pasmant E; Salles JP; Edouard T
    Bone Rep; 2021 Dec; 15():101097. PubMed ID: 34169121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.
    Mayr B; Schnabel D; Dörr HG; Schöfl C
    Eur J Endocrinol; 2016 May; 174(5):R189-208. PubMed ID: 26646938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful use of cinacalcet monotherapy in the management of siblings with homozygous calcium-sensing receptor mutation.
    Wade L; Aindow A; Isherwood L; Mughal MZ; Ramakrishnan R
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):549-556. PubMed ID: 35073615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients.
    Fisher MM; Cabrera SM; Imel EA
    Endocrinol Diabetes Metab Case Rep; 2015; 2015():150040. PubMed ID: 26161261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
    Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
    BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
    Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
    Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.